BioCryst Pharmaceuticals, Inc. Shareholders Equity and Liabilities (Total)

Shareholders Equity and Liabilities (Total) of BCRX for past 10 years: annual, quarterly and twelve month trailing (TTM) including Shareholders Equity and Liabilities (Total) growth rates and interactive chart.


Highlights and Quick Summary

  • Shareholders Equity and Liabilities (Total) for the quarter ending September 30, 2022 was $559 Million (a 9.41% increase compared to previous quarter)
  • Year-over-year quarterly Shareholders Equity and Liabilities (Total) decreased by -5.03%
  • Annual Shareholders Equity and Liabilities (Total) for 2021 was $588 Million (a 75.72% increase from previous year)
  • Annual Shareholders Equity and Liabilities (Total) for 2020 was $335 Million (a 90.96% increase from previous year)
  • Annual Shareholders Equity and Liabilities (Total) for 2019 was $175 Million (a 19.37% increase from previous year)
Visit stockrow.com/BCRX for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Shareholders Equity and Liabilities (Total) of BioCryst Pharmaceuticals, Inc.

Most recent Shareholders Equity and Liabilities (Total)of BCRX including historical data for past 10 years.

Interactive Chart of Shareholders Equity and Liabilities (Total) of BioCryst Pharmaceuticals, Inc.

BioCryst Pharmaceuticals, Inc. Shareholders Equity and Liabilities (Total) for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 $558.59 $510.54 $527.72
2021 $588.15 $265.76 $277.28 $284.43 $588.15
2020 $334.72 $176.23 $214.71 $136.59 $334.72
2019 $175.28 $90.5 $116.34 $142.34 $175.28
2018 $146.84 $168.31 $136.64 $155.37 $146.84
2017 $178.26 $191.49 $113.51 $129.51 $178.26
2016 $89.85 $91.5 $82.22 $102.88 $89.85
2015 $122.36 $138.96 $150.18 $129.87 $122.36
2014 $136.87 $137.13 $141.98 $43.39 $136.87
2013 $48.87 $53.21 $39.92 $46.9 $48.87
2012 $57.44 $64.09 $76.24 $80.09 $57.44

Business Profile of BioCryst Pharmaceuticals, Inc.

Sector: Healthcare
Industry: Biotechnology